Clinical TrialsSearch results
Number of results: 67288
Completed
- A Phase I/II study of mucosal immunotherapy using HPV-targeting Lactobacillus-based vaccine, IGMKK16E7, for treatment of HPV16-related high-grade squamous intraepithelial lesions: MILACLE study
- High-grade squamous intraepithelial lesions (HSIL/CIN2-3)
- Kawana Kei
- 2019-05-31
Completed
- A phase I/IIa study of STN1014100 ophthalmic solution in healthy adult male volunteers and dry eye patients
- Dry eye
- Koji Oka
- 2023-01-18
Completed
- A Phase Ia/Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Patients With Locally Advanced or Metastatic Tumors
- locally advanced, recurrent, or metastatic tumors
- Tien Hoang
- 2021-11-19
Completed
- A phase Ib study of Durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer
- cervical cancer
- Murata Kazutoshi
- 2021-05-12
Completed
- A phase II continuous clinical trial of peptide vaccination for cancer patients
- Malignant Tumor
- Yutani Shigeru
- 2019-03-19
Completed
- A phase II study evaluating the effect of Nivolumab in combination with palliative radiationtherapy in previously treated patients with NSCLC
- Non small cell lung cancer
- Satouchi Miyako
- 2019-03-26
Completed
- A Phase II Study of MR19A13A.
- Patients undergoing a scheduled surgery under general anesthesia.
- Nobuyo Oya
- 2022-10-27
Completed
- A phase II Study of CBDCA + ETP + Nintedanib for SCLC with IPF
- Unresectable limited or extensive disease small cell lung cancer with idiopathic pulmonary fibrosis
- IKEDA Satoshi
- 2019-10-18
Completed
- A Phase II Study of daily carboplatin plus irradiation followed by Durvalumab for previously-untreated Stage III NSCLC patients with PS2 and/or high age
- non-small cell lung cancer
- Kaira Kyoichi
- 2019-08-07
Completed
- A phase II study of gefitinib with TRT in patients with stage III NSCLC harboring EGFR mutations
- Non-Small Cell Lung Cancer
- Murakami Haruyasu
- 2019-03-11